Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Lavandula stoechas exerts its effects through volatile oil compounds, particularly fenchone, camphor, borneol, and 1,8-cineole. These constituents provide antispasmodic and analgesic properties that relax smooth muscle and reduce headache pain. The 1,8-cineole component demonstrates anti-inflammatory and bronchodilatory effects in laboratory studies, supporting traditional use for respiratory catarrh. Camphor acts as a central nervous system stimulant at low doses but can provoke excitatory effects at higher concentrations. Evidence level: B (preclinical data supporting traditional use).
Does Lavender Stoechas interact with any medications?
Lavandula stoechas may interact with central nervous system medications due to its camphor content, which possesses stimulant properties. It could potentially antagonize the effects of sedatives, anticonvulsants, and anxiolytics. Patients taking anticoagulants should exercise caution, as some lavender constituents may affect bleeding time. The herb may also affect liver enzyme metabolism of certain drugs. Always consult a qualified healthcare practitioner before combining herbal remedies with prescription medications. Evidence level: C (theoretical interactions based on constituent pharmacology).
What is the recommended dosage for Lavandula stoechas?
The traditional adult dosage for Lavandula stoechas is 2-4 grams of dried flowers prepared as a tea, taken up to three times daily. For essential oil use, 2-4 drops diluted in a carrier oil or appropriate vehicle is the recommended daily amount. The oil should never be taken undiluted internally. Due to camphor content, doses should not exceed recommendations, as higher amounts may cause headache, nausea, or neurological symptoms. Evidence level: B (established traditional use with pharmacopoeial standards).
Is Lavender Stoechas safe during pregnancy and breastfeeding?
No, Lavandula stoechas is considered unsafe during pregnancy and should be strictly avoided. The camphor content can cross the placenta and may stimulate uterine contractions or cause fetal toxicity. Traditional use as an emmenagogue indicates historical use to induce menstruation, posing clear risks during pregnancy. Breastfeeding women should also avoid this herb due to insufficient safety data and potential for camphor to pass into breast milk. Evidence level: D (extrapolated from constituent toxicity data).
Can Lavender Stoechas be used to treat epilepsy?
Despite historical folk medicine use for epilepsy, Lavandula stoechas is now contraindicated for this condition. The camphor content, comprising up to 30% of the essential oil, has pro-convulsant properties and may provoke seizures in susceptible individuals, particularly at higher doses. This represents an important distinction from Lavandula angustifolia (common lavender), which contains negligible camphor. Patients with epilepsy should avoid this species entirely and consult a neurologist for appropriate treatment. Evidence level: D (case reports and pharmacological extrapolation).
What side effects can Lavandula stoechas cause?
Lavandula stoechas may cause skin sensitization and allergic contact dermatitis, particularly with undiluted essential oil application. Internal use exceeding recommended doses can cause headache, nausea, dizziness, and confusion due to camphor content. Excessive camphor intake may lead to neurological symptoms including seizures, especially in children and those with epilepsy. Those with known allergies to Lamiaceae family plants should exercise caution. Discontinue use if adverse neurological symptoms occur. Evidence level: C (adverse event reports and constituent toxicity).
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Lavandula stoechas, also known as French or Spanish lavender, is a Mediterranean medicinal plant recognized for its diverse pharmacological potential, including anti-inflammatory, antimicrobial, and antidiabetic activities [PMID:39641378, 36984777].
Contexte
Lavandula stoechas is an aromatic shrub widely present in the Mediterranean region [PMID:36984777, 41304589]. It is utilized in pharmaceutical, flavor, fragrance, and food industries due to its essential oil production [PMID:36984777].
Usages traditionnels
Since ancient times, it has been used in traditional medicine for internal and external purposes [PMID:36984777, 32452196]. Specific traditional applications include managing inflammatory diseases [PMID:40292266], treating neurodegenerative disorders such as Parkinson's disease in European and Persian medicine [PMID:33716081], and treating diabetes in Moroccan traditional medicine [PMID:37683576, 39539624]. Anatolian people have traditionally used decoctions and infusions of the aerial parts against components of metabolic syndrome, including type II diabetes and cardiovascular diseases [PMID:29729383]. It has also been used as a smoking cessation aid [PMID:41866519].
Composés actifs
The plant contains a diverse range of bioactive substances, including flavonoids, terpenes, and phenolic acids [PMID:39641378]. Essential oils are characterized by high amounts of 1,8-cineole, camphor, fenchone, and borneol [PMID:36984777, 40168180, 30697296]. L. stoechas subsp. luisieri specifically contains trans-α-necrodyl acetate and trans-necrodol [PMID:36984777, 41304589]. Other identified compounds include ursolic acid [PMID:37338138], phenethylamine, and α-tocopherol [PMID:34205806].
Mécanisme d'action
L. stoechas extracts have demonstrated the ability to inhibit enzymes such as α-glycosidase, acetylcholinesterase, butyrylcholinesterase, and human carbonic anhydrase I and II [PMID:37338138]. Its antihyperglycemic effects are linked to the inhibition of pancreatic α-amylase and intestinal α-glucosidase, as well as the reduction of intestinal d-glucose absorption [PMID:37683576]. In neuroprotection, essential oils may prevent the generation and deposition of neurotoxic β-amyloid peptide [PMID:32452196].
Preuves cliniques
Preuve ALabor Pain
A systematic review and meta-analysis indicated that lavender can reduce labor pain, although results across original studies were controversial [PMID:33224252].
Preuve BVenipuncture Pain in Preterm Infants
Aromatherapy with L. stoechas significantly lowered pain intensity during and after venipuncture compared to a sham group, though breast milk odor was more effective [PMID:37635050].
Preuve DDiabetic Wound Healing
In an experimental rat model of diabetes, L. stoechas showed significant differences in wound dimensions on days 7, 14, and 21 [PMID:37829966].
Preuve DHyperglycemia
Aqueous extract (150 mg/kg) significantly reduced postprandial hyperglycemia in normal and diabetic Wistar rats [PMID:37683576].
Preuve DAcute Asthma
Hydro-alcoholic extract (200 and 300 mg/kg) demonstrated anti-inflammatory effects in a mice model of ovalbumin-induced acute asthma [PMID:40292266].
Preuve D
Sécurité et effets indésirables
Albino mice were used to assess toxicity of the aqueous extract, though specific adverse effects were not detailed in the provided abstracts [PMID:37683576].
Synthèse des preuves
The evidence consists primarily of in vitro studies and animal models (Level D), with limited clinical data including one systematic review on labor pain (Level A) and one RCT on neonatal pain (Level B).
Sources PubMed
1.PMID: 36984777 (2023) — Mediterranean Lavenders from Section Stoechas: An Undervalued Source of Secondary Metabolites with Pharmacological Potential. · Metabolites
2.PMID: 37829966 (2023) — The Effect of Lavandula stoechas on Wound Healing in an Experimental Diabetes Model. · Cureus
3.PMID: 39641378 (2025) — A Comprehensive Review of Lavandula stoechas L. (Ustukhuddus) Plant: Phytochemistry, Pharmacology, and In Silico Studies. · Chemistry & biodiversity
4.PMID: 37338138 (2023) — Lavandula stoechas L. subsp. stoechas, a New Herbal Source for Ursolic Acid: Quantitative Analysis, Purification and Bioactivity Studies. · Chemistry & biodiversity
5.PMID: 41304951 (2025) — Anticancer Effects and Phytochemical Profile of Lavandula stoechas. · Pharmaceuticals (Basel, Switzerland)
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
Ethanol and methanol extracts reduced viability of cancer cells (MDA-MB-231, T98G, RT4) in a dose- and time-dependent manner, with fresh ethanol extract showing the highest potency [PMID:41304951].
Preuve DMemory/Nootropic Activity
Oral administration of purified aqueous extract fractions improved the inflexion ratio in scopolamine-induced hyper-amnesic albino mice [PMID:34205806].
6.PMID: 38591060 (2024) — Comparative study of the chemical composition, antioxidant, and antimicrobial activity of the essential oils extracted from Lavandula abrialis and Lavandula stoechas: in vitro and in silico analysis. · Frontiers in chemistry
7.PMID: 33224252 (2020) — The Effect of Lavender (Lavandula stoechas L.) on Reducing Labor Pain: A Systematic Review and Meta-Analysis. · Evidence-based complementary and alternative medicine : eCAM
8.PMID: 34205806 (2021) — Biomolecular Evaluation of Lavandula stoechas L. for Nootropic Activity. · Plants (Basel, Switzerland)
9.PMID: 32452196 (2020) — Essential oils of spontaneous species of the genus Lavandula from Portugal: a brief review. · Zeitschrift fur Naturforschung. C, Journal of biosciences
10.PMID: 40292266 (2025) — Exploring the anti-inflammatory effects of Lavandula stoechas L. extract on ovalbumin-induced acute asthma in BALB/c mice. · Avicenna journal of phytomedicine
11.PMID: 27269390 (2016) — Anti-inflammatory activity of hydroalcoholic extracts of Lavandula dentata L. and Lavandula stoechas L. · Journal of ethnopharmacology
12.PMID: 32806608 (2020) — A New Eucalyptol-Rich Lavender (Lavandula stoechas L.) Essential Oil: Emerging Potential for Therapy against Inflammation and Cancer. · Molecules (Basel, Switzerland)
13.PMID: 33716081 (2021) — Protective effects of Lavandula stoechas L. methanol extract against 6-OHDA-induced apoptosis in PC12 cells. · Journal of ethnopharmacology
14.PMID: 41304589 (2025) — Lavandula stoechas subsp. luisieri (Rozeira) Rozeira: Variability of Chemical Composition of Essential Oil in Wild Populations. · Plants (Basel, Switzerland)
15.PMID: 37729996 (2023) — Lavandula stoechas extract incorporated polylactic acid nanofibrous mats as an antibacterial and cytocompatible wound dressing. · International journal of biological macromolecules
16.PMID: 29729383 (2018) — Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions. · Journal of ethnopharmacology
17.PMID: 40255688 (2025) — Antibiofilm potential of plant extracts: inhibiting oral microorganisms and Streptococcus mutans. · Frontiers in dental medicine
18.PMID: 37683576 (2023) — Antihyperglycemic potential of the Lavandula stoechas aqueous extract via inhibition of digestive enzymes and reduction of intestinal glucose absorption. · Journal of Ayurveda and integrative medicine
19.PMID: 39539624 (2024) — Antidiabetic potential of Lavandula stoechas aqueous extract: insights into pancreatic lipase inhibition, antioxidant activity, antiglycation at multiple stages and anti-inflammatory effects. · Frontiers in pharmacology
20.PMID: 30697296 (2018) — The Effect of Lavandula Stoechas on Toxigenesis and the Growth of Vibrio Parahaemolyticus. · Iranian journal of pathology
21.PMID: 15373716 (2004) — Herbs as a food source in Turkey. · Asian Pacific journal of cancer prevention : APJCP
22.PMID: 38138621 (2023) — Mediterranean Shrub Species as a Source of Biomolecules against Neurodegenerative Diseases. · Molecules (Basel, Switzerland)
23.PMID: 31586515 (2020) — Chiroptical fingerprints to characterize lavender and lavandin essential oils. · Journal of chromatography. A
24.PMID: 36767025 (2023) — Antimicrobial Properties of Essential Oils Obtained from Autochthonous Aromatic Plants. · International journal of environmental research and public health
25.PMID: 33882591 (2021) — Proposals for Antimicrobial Testing Guidelines Applied on Ajowan and Spanish Lavender Essential Oils. · Planta medica
26.PMID: 41466096 (2025) — The role of Lavandula stoechas L. extract in enhancing tolerance to prometryn toxicity. · Scientific reports
27.PMID: 37635050 (2024) — Comparing the effect of aromatherapy with breast milk, Lavandula stoechas, and Rosa damascena on venipuncture pain in preterm infants. · Explore (New York, N.Y.)
28.PMID: 41866519 (2026) — Anti-inflammatory and antioxidant effects of Lavandula stoechas L. on human macrophages and in silico prediction of α7 nicotinic acetylcholine receptor interaction. · BMC complementary medicine and therapies
29.PMID: 15612826 (2004) — Chemical compositions and antibacterial effects of essential oils of Turkish oregano (Origanum minutiflorum), bay laurel (Laurus nobilis), Spanish lavender (Lavandula stoechas L.), and fennel (Foeniculum vulgare) on common foodborne pathogens. · Journal of agricultural and food chemistry
30.PMID: 40168180 (2025) — Phytochemistry and Antiproliferative Potential of a Naturalized Plant in Jordan: Lavandula stoechas. · Chemistry & biodiversity